IMMUNOGLOBULIN E - ANVISA Registration 80254180012

Access comprehensive regulatory information for IMMUNOGLOBULIN E in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80254180012 and manufactured by PHADIA AB. The registration is held by PHADIA DIAGNOSTICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including PHADIA AB, SHENZHEN DYMIND BIOTECHNOLOGY CO., LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80254180012
Registration Details
ANVISA Registration Number: 80254180012
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

šŸ‡§šŸ‡· Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

IMMUNOCAP SPECIFIC IGE CONJUGATE 400
Risk Class II

Registration Details

80254180012

25351278835200537

04930429000139

Company Information

PHADIA AB
Sweden
PT: SUƉCIA

Dates and Status

Sep 12, 2005

VIGENTE

09/18/2025 19:00:01